IQVIA Holdings Inc. Common Stock (IQV)
Stock · NYSE · Health Care
$261.75as of 8/28/2026
Price chart
Open in TradingViewActive signals
About IQV
IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud…
- Sector
- Health Care
- Industry
- Biotechnology: Commercial Physical & Biological Resarch
- Employees
- 94,000
- Website
- ir.iqvia.com/
Fundamentals
- 1-day range
- $258.08$262.78
- Market cap
- $38.41B
- P/E (trailing)
- 28.64
- P/E (forward)
- 18.10
- EPS (trailing)
- $8.07
- Dividend yield
- —
- Beta
- 1.19
- Avg. volume
- 1.45M
How IQVIA Holdings Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 17, 2026 · via SEC EDGAR / Finnhub
Forecasts
18 analyst ratings
IQVIA Holdings Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- IQVIQVIA Holdings Inc. Common Stock$261.54▼ 0.32%Market cap $38.41BP/E 28.64$154.5$265.25
- INCYIncyte Corp. Common Stock$124.39▼ 2.63%Market cap $24.01BP/E 15.14$81.09$132.6
- MEDPMedpace Holdings Inc. Common Stock$599.99▼ 1.89%Market cap $16.00BP/E 33.13$373$677.9
- ICLRICON plc Ordinary Shares$169.84▲ 0.07%Market cap $12.13BP/E 183.55$66.57$203.91
- CRLCharles River Laboratories International Inc. Common Stock$291.74▼ 1.58%Market cap $11.12BP/E —$144.26$303.31
- ABSIAbsci Corporation Common Stock$8.72▼ 7.43%Market cap $1.24BP/E —$2.24$12.06
- ONMDOneMedNet Corp Class A Common Stock$0.5801▼ 0.84%Market cap $43.24MP/E —$0.49$4.22
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| IQV IQVIA Holdings Inc. Common Stock | $38.41B | 28.64 | $261.54 | ▼ 0.32% | $154.5$265.25 |
| INCY Incyte Corp. Common Stock | $24.01B | 15.14 | $124.39 | ▼ 2.63% | $81.09$132.6 |
| MEDP Medpace Holdings Inc. Common Stock | $16.00B | 33.13 | $599.99 | ▼ 1.89% | $373$677.9 |
| ICLR ICON plc Ordinary Shares | $12.13B | 183.55 | $169.84 | ▲ 0.07% | $66.57$203.91 |
| CRL Charles River Laboratories International Inc. Common Stock | $11.12B | — | $291.74 | ▼ 1.58% | $144.26$303.31 |
| ABSI Absci Corporation Common Stock | $1.24B | — | $8.72 | ▼ 7.43% | $2.24$12.06 |
| ONMD OneMedNet Corp Class A Common Stock | $43.24M | — | $0.5801 | ▼ 0.84% | $0.49$4.22 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- CRL Jumps 33.3% in the Past Month: Can This Strong Rally Keep Running?Yahoo · 8/21/2026
- IQVIA Holdings Stock Outlook: Is Wall Street Bullish or Bearish?Yahoo · 8/21/2026
- IQVIA's AI-Enabled Clinical Decision Support Tool Wins 2026 AI Breakthrough Award for Predictive Modeling Solution of the YearYahoo · 8/20/2026
- Exploring the top movers within the S&P500 index during today's session.ChartMill · 8/20/2026
- Thursday's session: top gainers and losers in the S&P500 indexChartMill · 8/20/2026
- Tempus AI Just Had Their Entire Strategy Validated By Moderna's Vaccine AdvanceSeekingAlpha · 8/20/2026
- IQVIA Ranked No. 1 Pharmaceutical Technology Provider by Everest GroupYahoo · 8/17/2026
- IHF: Healthcare Dashboard For AugustSeekingAlpha · 8/16/2026
Insider Activity
Insider Actions →- STAUB W RICHARD · August 3, 2026 · Sale5.5K @ $232.68
- Patel Bhavik · July 31, 2026 · Sale1.9K @ $235.27
- Sherbet Eric · July 29, 2026 · Sale5.0K @ $249.16
- Cherofsky Keriann · July 29, 2026 · Sale558 @ $245.21
- BOUSBIB ARI · July 29, 2026 · Option Exercise156.2K @ $78.21
- BOUSBIB ARI · July 29, 2026 · Disposition2.1K @ $247
- BOUSBIB ARI · July 29, 2026 · Disposition47.9K @ $244.6
- BOUSBIB ARI · July 29, 2026 · Sale53.2K @ $244.78
- BOUSBIB ARI · July 29, 2026 · Sale44.0K @ $246.08
- BOUSBIB ARI · July 29, 2026 · Sale4.6K @ $246.85
- BOUSBIB ARI · July 29, 2026 · Sale4.5K @ $247.1
- Wims Morris Leslie · July 14, 2026 · Grant148 @ $207.83
- Fasano Jim · July 14, 2026 · Grant195 @ $207.83
- GOGGINS COLLEEN A · July 14, 2026 · Grant183 @ $207.83
- DANHAKL JOHN G · July 14, 2026 · Grant160 @ $207.83
Institutional Ownership
March 31, 2026
- Total shares held
- 142.73M
- Total value held
- $23.67B
- Institutional holders
- 1055
- Unknown15.03M
- Unknown12.18M
- Unknown11.03M
- Unknown7.48M
- Unknown5.06M
- Unknown4.46M
- Unknown4.24M
- Unknown3.26M
- Unknown2.88M
- Unknown2.61M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedSynthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
August 28, 2026
IQVIA Draws Attention as Analysts Weigh Outlook After Strong Run. IQVIA recently appeared in market coverage discussing analyst sentiment and broader healthcare peer performance, with one article noting a 33.3% monthly gain in a comparable stock. A separate piece examined whether Wall Street is leaning bullish or bearish on IQVIA's near-term outlook. Together, the coverage reflects heightened investor focus on the stock following its recent strength, as the company sits near a well-tested support level of $163.42 and shows an elevated RSI reading, signals readers can view on the chart alongside this commentary.